Lab-test results of Optimer indicate good applicability in deodorant products.
From Aptamer GroupSep 3 2024 Aptamer Group plc , the developer of novel Optimer® binders to enable innovation in the life sciences industry, is pleased to announce an extension of its partnership with Unilever to enter a new phase aimed at initiating in-vivo efficacy testing of Optimer binders as active ingredients in deodorants.
Initiated in 2022, the partnership between Aptamer and Unilever aims to develop Optimer binders as part of novel deodorant products. The current market value for deodorants is in excess of $21 billion per annum and growing at 4.5% . Unilever is the leader in the deodorant market, with over 30% market share - an increase of over 20% compared to its nearest competitor.
Related StoriesUnilever will continue to progress the developed Optimer binders through rigorous internal testing. It plans to initiate in-vivo efficacy studies before the end of 2024. A successful outcome from these trials will then lead to next steps in the partnership.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Elon Musk sues Unilever and Mars over X advertising 'boycott'The social media site claims the firms unfairly deprived it of billions of dollars of advertising revenue.
Read more »
Scots NHS lab specimens flown by drone in ground-breaking new moveThe specimens were flown between Edinburgh BioQuarter next to the Royal Infirmary of Edinburgh and Borders General Hospital in Melrose.
Read more »
Effective lab data management: New solutions for modern research (Part 2)This article discusses the importance of effective lab data management, highlighting the challenges and benefits of integrating systems like LIMS and ELNs to improve efficiency, data accessibility, and compliance in modern research laboratories.
Read more »
Effective lab data management: Advancing scientific research (Part 1)This article explains the importance of effective lab data management and the benefits of centralized systems for storing, analyzing, and sharing scientific data, highlighting how integrated solutions enhance research efficiency and collaboration.
Read more »
Routine lab tests are not a reliable way to diagnose long COVID, finds studyA National Institutes of Health (NIH)-supported study has found that routine lab tests may not be useful in making a long COVID diagnosis for people who have symptoms of the condition.
Read more »
NIH study finds routine lab tests fall short in diagnosing long COVIDA National Institutes of Health (NIH)-supported study has found that routine lab tests may not be useful in making a long COVID diagnosis for people who have symptoms of the condition
Read more »